Cargando…
A Double Blind, Randomized, Placebo Controlled Clinical Study Evaluates the Early Efficacy of Aflapin(®) in Subjects with Osteoarthritis of Knee
Aflapin(®) is a novel synergistic composition derived from Boswellia serrata gum resin (Indian Patent Application No. 2229/CHE/2008). Aflapin is more efficacious as an anti-inflammatory agent compared to the existing Boswellia products, 5-Loxin(®) and traditional 65% Boswellia extract. A 30-day, dou...
Autores principales: | Vishal, Amar A., Mishra, Artatrana, Raychaudhuri, Siba P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198257/ https://www.ncbi.nlm.nih.gov/pubmed/22022214 |
Ejemplares similares
-
Comparative Efficacy and Tolerability of 5-Loxin(®) and Aflapin(® )Against Osteoarthritis of the Knee: A Double Blind, Randomized, Placebo Controlled Clinical Study
por: Sengupta, Krishanu, et al.
Publicado: (2010) -
Management strategies for knee osteoarthritis: Aflapin(®) (Boswellia serrata extract)
por: Suva, Manoj A., et al.
Publicado: (2017) -
A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin(® )for treatment of osteoarthritis of the knee
por: Sengupta, Krishanu, et al.
Publicado: (2008) -
The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Bolten, Wolfgang W., et al.
Publicado: (2015) -
The Clinical Efficacy and Safety of Gumiganghwal-Tang in Knee Osteoarthritis: A Phase II Randomized Double Blind Placebo Controlled Study
por: Chang, Sung Hae, et al.
Publicado: (2018)